TrialCard TALK: Recent Episodes
TrialCard
On paper, we are a technology-driven life sciences solutions company.But on a daily basis, we make sure patients come first.We do this by providing the life sciences industry with an integrated suite ofsolutions that enhance patient and provider experiences. And better experiences lead to better outcomes. When TrialCard was founded in 2000, we knew that an all-inclusive enterprise management system was essential for an easily accessible, user-friendly patient experience. We’ve spent the last several yearsexpanding and perfecting our services, that prioritize patientsand simplify access to the care they deserve.
On this episode of Mercalis in Motion, Sean Boyler, Tom Gottschalk, and Robbie Hill join us in the studio to commemorate the 15-year anniversary of RxStudy Card. What follows is a conversation about how RxStudy Card by Mercalis has evolved over the years to save our clients millions of dollars in time and money while eliminating waste associated with the traditional clinical trial supply process.
Today, Landy and Eric welcome three members of the Mercalis Products Team to the studio. Bill Dupere, Stephanie Chesebro, and Nick Hill stopped by to discuss recent developments related to the Mercalis eServices and Curator capabilities. In November 2023, Mercalis announced an exclusive perpetual license to a portfolio of access and adherence technologies from OptimizeRx. Since then, the Products Team has been busy integrating and enhancing its catalog of market-leading patient support services offerings.
In this episode, Heather Smith, PhD, RN, NNP visits the studio to discuss the Mercalis Nurse Network. For the past seven years, Mercalis has provided its clients and their patients with a growing suite of services focused on patient care and education. The need for our Nurse Network was realized when we observed that parents and caregivers were being asked to mix medications and inject their children or family members. Since then, Mercalis nurses have served as an important link in the education of caregivers, leading to better adherence and superior outcomes for countless patients.
In this episode, Landy and Eric sit down with Jason Zemcik, Andrea Xu, and Bethany Najer of Policy Reporter by Mercalis to dive into a number of issues that are facing the life sciences market, as well as an update on Policy Reporter's offerings and what's on the horizon for the growing healthcare information management company . Tune in for a thought-provoking conversation about market dynamics and advancements in market access.
Today on Mercalis in Motion, we’re pleased to share a two-part episode featuring three of our colleagues from Triangle Insights Group by Mercalis. Triangle, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. On this episode, Matt Haynes and Meghna Shankar discuss a recent white paper titled “The Indirect Impacts of the Inflation Reduction Act on Pharmaceutical Pipeline and Portfolio Strategy”, co-authored by Shankar and Triangle Principal Megan Thomas. Then, Landy speaks with Triangle Executive Vice President & General Manager Rohit Kumar, who recently joined the company in November 2023. Kumar discusses what brought him to Triangle and shares his vision for the firm and how it will continue to integrate with Mercalis and Policy Reporter to provide value to life sciences companies.
Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically takes place on or near the last day of February. In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two guests from Catalyst Pharmaceuticals — Amy Grover, Senior Director of Patient Advocacy and Carrie Ostrea, Senior Manager of Patient Advocacy. We are also joined by our Mercalis colleague John Katter, who serves as a Director, Business Development. Please join us as Amy, Carrie, and John discuss the importance of acknowledging the rare disease community and highlight the work that Catalyst and Mercalis have done for this very important patient population.
Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024. Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in 2024 and beyond.
In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or just tuning in, join us for a review of the conversations that shaped our year.
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss the latest updates via a roundtable discussion. We welcomed to the studio our colleague Michael Harris, Mercalis’ VP of Patient Support Services Strategy. He was joined by Carl Schmid, the Executive Director at the HIV + Hepatitis Policy Institute and Bill Sarraille, a Partner with the Sidley law firm in Washington, D.C. This information will be very helpful to life sciences decision makers who are planning for 2024 and beyond.
In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercialization partner.
Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs has introduced new access challenges for patients, plans, and manufacturers alike.
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter.
In this episode of TrialCard TALK, we welcome to the studio Chris Harris, TrialCard's Vice President of Operations, to discuss the growth and impact that TrialCard's non-commercial dispensing pharmacy has had on the organization and its clients.
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive revenue, enhance operational efficiency, and decrease exposure to regulatory risk for pharma and biotech manufacturers, specialty pharmacies, payers, and hospitals/IDNs. Mr. Erhardt has over 30 years of strategic marketing and management experience across both the consumer product and pharmaceutical arenas. His experience has spanned several Fortune 500 organizations, including Express Scripts, Cardinal Health, and U.S. Healthcare.
Download this episode to learn more about the everchanging healthcare landscape and what Mr. Erhardt sees ahead for life science companies, payers, and patients.
TrialCard CEO, Scott Dulitz, joins Landy and Eric on the first podcast of 2023 to reflect upon TrialCard’s success in 2022 and look ahead at some of the trends in the market that will define 2023.
In the final episode of TrialCard TALK for 2022, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect on the guests we have featured during the year and some of the highlights from each insightful conversation. Download now to enjoy the best of our 2022 discussions.
In the latest episode of TrialCard TALK, we speak to Bill Dupere, VP for Product Development for Patient Services, and Stephanie Chesebro, Product Owner – eServices on our IT Development Team, about TrialCard’s eServices and ‘Orchestrator’ solution. Bill and Stephanie explain how Orchestrator allows our life science clients to access many eService providers through one contract with TrialCard, which enables them to focus on what really matters: simplifying access to therapy for their patients. Download the podcast to hear more about how Orchestrator is evolving and further streamlining eService provider management in our industry.
In this episode of TrialCard TALK, we are joined by Tim Ogren, General Manager, and Peter Weissberg, Managing Director, at Policy Reporter – a TrialCard Company. Tim and Peter speak to us about the difference that the company makes to its clients – and ultimately, patients – through its innovative healthcare software solutions, which improve the way the medical and pharmaceutical industry receives, processes, and acts on policy developments.
Download this podcast to learn about the market dynamics that are driving demand for these solutions, why providers are increasingly reporting that the Policy Reporter platform is their go-to for updates in this space, and how the company is bringing a human element to its data through its new Policy Reporter Partners community.
In this episode of TrialCard TALK, Tom Gottschalk, Senior Director of Business Development for TrialCard, outlines how we support biotech and pharmaceutical companies’ clinical trial supply needs through our RxStudy Card™ – an innovative product that generates significant cost and time savings.
Download this podcast to learn how TrialCard brings high value to our clinical supply partnerships through our consultative approach, ongoing investments into the clinical trial industry, and strategic partnerships that enable us to meet global needs.
In the latest episode of TrialCard TALK, Molly Stallings, Vice President of PatientLink and Patient Experience at TrialCard, explains how our new patient communication platform takes patient engagement to the next level. PatientLink by TrialCard, an enterprise SaaS platform, is designed to simplify access and engagement with patient support programs. Download this podcast to hear how this omnichannel experience brings life science leaders one step closer to meeting the needs of today’s demanding healthcare marketplace, and empowers them to deliver more highly personalized patient support experiences than ever before.
Following TrialCard’s recent acquisition of Triangle Insights Group, Landy and Eric welcome two of the strategy consulting firm’s founding partners to the studio this month. In this discussion, we speak to Gautam Aggarwal and Chris Apolito about how Triangle’s strategic capabilities, combined with TrialCard’s industry-leading suite of patient support and provider engagement services, will enable us to provide greater value and support to our clients.
To commemorate National Nurses Week, Landy and Eric welcomed Heather Smith, PhD, RN, NNP to the studio to discuss the role that nurses play in TrialCard’s Patient Services offerings. Dr. Smith, who serves as Senior Program Director, Hub Services at TrialCard, also discusses nurses’ evolving roles through the years, the future of nursing, and what sets TrialCard’s Nursing Team apart from other providers.
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Michael Carlin, General Manager of Engage HCP by TrialCard.
The number of no see or difficult to see HCPs has risen dramatically in recent years and has been greatly exacerbated by COVID-19. Despite this growing trend, life science companies still must reach and educate HCPs about new and existing therapies. To accomplish this, TrialCard recently launched Engage HCP by TrialCard, a new expanded suite of services that serves as a complement to a biopharma brand’s field teams. Engage HCP supports brands at any stage of the product life cycle by providing the following disciplines:
- Clinical Nurse Educators
- Field Reimbursement Managers
- Pharmaceutical Institutional, Sales, and Specialty Representatives
- Rare Disease Professional
- Telepromotion Agents
- Medical Science Liaisons
Carlin discusses with Landy how hiring, training, and technology have separated TrialCard from other providers in this space, which has greatly benefitted the brands that TrialCard serves.
In this episode of TrialCard TALK, Landy and Eric welcome TrialCard’s two most senior executives to the studio: Scott Dulitz, President & Chief Strategy Officer and Joe Abdalla, President & Chief Commercial Officer. Scott and Joe discuss TrialCard’s recent successes, future plans, and their vision for the full-service life sciences commercialization partner.
In this episode of TrialCard TALK, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect back on our guests from this first season and highlights from each conversation.
In the latest episode of TrialCard TALK, Molly Stallings, Vice President of Product Marketing at TrialCard, discusses the evolving digital landscape and how it impacts the delivery of patient support programs. Download the podcast to hear how TrialCard is effectively engaging patients and caretakers with its life sciences multi-channel communication platform.
In this month's episode of TrialCard TALK, TrialCard's Kelly Bennett, Vice President and Practice Lead, Patient Affordability, joins us to discuss the evolution of the co-pay and financial assistance landscape. Kelly shares the many financial barriers patients encounter, and how the team has customized and enhanced the ways in which it delivers financial navigation to its life sciences partners.
In this episode of TrialCard TALK, Landy and Eric welcomed to the studio the Engage HCP team: General Manager Mark Droke, SVP, Commercial Solutions Tom Heck, VP, Commercial Solutions Mike Davis, and Product Director Ann Poorboy.
The number of no see or difficult to see HCPs has risen dramatically in recent years and has been greatly exacerbated by COVID-19. In fact, many predict that HCP access rates may never return to pre-pandemic levels. Recently, TrialCard launched Engage HCP, a new expanded suite of longstanding services that serves as a complement to a biopharma brand’s field teams. Join us for an informative conversation that describes how Engage HCP supports brands at any stage of product life cycle by providing the following disciplines:
- Clinical Nurse Educators
- Field Reimbursement Managers
- Pharmaceutical Institutional, Sales, and Specialty Representatives
- Rare Disease Professionals
- Telepromotion Agents
- Medical Science Liaisons
The risk environment facing co-pay assistance programs has expanded significantly in recent years. Legislative and policy developments, payer tactics, and ill-intentioned actors present financial, operational, and compliance issues if not properly understood and addressed. TrialCard’s TC Synapse suite combines industry-leading subject matter expertise and proprietary data-driven controls to ensure your program is safeguarded against multiple threat areas. In this episode, Jason Zemcik, Vice President and Patient Affordability Practice Lead, discusses how TC Synapse is helping pharmaceutical manufacturers remain ahead of emerging trends in co-pay program risk to ensure the integrity of their program.
In this episode of TrialCard TALK, Landy and Eric welcome Mark Boesen, J.D., Pharm.D. from TC Script, TrialCard's non-commercial dispensing pharmacy located in Scottsdale, AZ. Mark discusses how TC Script has continued TrialCard's longstanding promise to always take care of patients.
In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward.
.
In this podcast, TrialCard’s Clinical Support Services leaders, Dianne Higgins and Heather Smith discuss the value of nursing support in market access programs and how the evolution of technology is transforming the industry’s patient engagement methodologies.
In this episode, Latrinda Riley joins Landy Townsend, Vice President of Marketing at TrialCard, to discuss her new role as the Director of Diversity, Equity, and Inclusion. Listen to learn more about Latrinda’s background, how she managed challenges brought on by the COVID-19 pandemic, and the new initiatives she has planned for the organization.
The COVID-19 pandemic has significantly impacted clinical operations and accelerated decentralized clinical trial models. In this podcast, TrialCard’s SVP of Business Development, Tom Heck, discusses the importance of an efficient clinical supply management process and how TrialCard’s RxStudy Card™ achieves that. Listen to this episode to understand the many benefits of the RxStudy Card™ in today’s current environment and how we see it being utilized in the future.
In this episode of TrialCard TALK, our guest is Rick Ford, Vice President of Data Marketing for Policy Reporter, a TrialCard company. Rick discusses how Policy Reporter accelerates TrialCard’s mission to create the leading end-to-end patient access solutions organization by granting its clients increased visibility into health plan policy information.